Maplightrx
154 employees on LinkedIn · 1 known investors
Find your way into Maplightrx
MapLight develops neurological and neuropsychiatric drug therapies using a discovery platform that identifies neural circuits linked to disease for targeted treatment of conditions like schizophrenia, Alzheimer's disease psychosis, and autism spectrum disorder.
Founders & leadership
CK
Christopher Kroeger, M.D.Chief Executive Officer, Founder, Board Member
KD
Karl Deisseroth, M.D., Ph.D.Founder, Scientific Advisory Board
RM
Robert Malenka, M.D., Ph.D.Founder, Board Member, Scientific Advisory Board
Investors · 1
Frequently asked questions
- What does Maplightrx do?
- MapLight develops neurological and neuropsychiatric drug therapies using a discovery platform that identifies neural circuits linked to disease for targeted treatment of conditions like schizophrenia, Alzheimer's disease psychosis, and autism spectrum disorder.
- Who founded Maplightrx?
- Maplightrx was founded by Christopher Kroeger, M.D., Karl Deisseroth, M.D., Ph.D., Robert Malenka, M.D., Ph.D..
- Who are Maplightrx's investors?
- Maplightrx's investors include Avego BioScience Capital.